Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time: An IMI-DIRECT study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time : An IMI-DIRECT study. / Obura, M.; Beulens, J. W. J.; Slieker, R.; Koopman, A. D. M.; Hoekstra, T.; Nijpels, G.; Elders, P.; Dekker, J. M.; Koivula, R. W.; Kurbasic, A.; Laakso, M.; Hansen, T. H.; Ridderstråle, M.; Hansen, T.; Pavo, I.; Forgie, I.; Jablonka, B.; Ruetten, H.; Mari, A.; McCarthy, M. I.; Walker, M.; McDonald, T. J.; Perry, M. H.; Pearson, E. R.; Franks, P. W.; 't Hart, L. M.; Rutters, F.

In: Diabetic Medicine, Vol. 38, No. 2, 14428, 2021.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Obura, M, Beulens, JWJ, Slieker, R, Koopman, ADM, Hoekstra, T, Nijpels, G, Elders, P, Dekker, JM, Koivula, RW, Kurbasic, A, Laakso, M, Hansen, TH, Ridderstråle, M, Hansen, T, Pavo, I, Forgie, I, Jablonka, B, Ruetten, H, Mari, A, McCarthy, MI, Walker, M, McDonald, TJ, Perry, MH, Pearson, ER, Franks, PW, 't Hart, LM & Rutters, F 2021, 'Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time: An IMI-DIRECT study', Diabetic Medicine, vol. 38, no. 2, 14428. https://doi.org/10.1111/dme.14428

APA

Obura, M., Beulens, J. W. J., Slieker, R., Koopman, A. D. M., Hoekstra, T., Nijpels, G., Elders, P., Dekker, J. M., Koivula, R. W., Kurbasic, A., Laakso, M., Hansen, T. H., Ridderstråle, M., Hansen, T., Pavo, I., Forgie, I., Jablonka, B., Ruetten, H., Mari, A., ... Rutters, F. (2021). Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time: An IMI-DIRECT study. Diabetic Medicine, 38(2), [14428]. https://doi.org/10.1111/dme.14428

Vancouver

Obura M, Beulens JWJ, Slieker R, Koopman ADM, Hoekstra T, Nijpels G et al. Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time: An IMI-DIRECT study. Diabetic Medicine. 2021;38(2). 14428. https://doi.org/10.1111/dme.14428

Author

Obura, M. ; Beulens, J. W. J. ; Slieker, R. ; Koopman, A. D. M. ; Hoekstra, T. ; Nijpels, G. ; Elders, P. ; Dekker, J. M. ; Koivula, R. W. ; Kurbasic, A. ; Laakso, M. ; Hansen, T. H. ; Ridderstråle, M. ; Hansen, T. ; Pavo, I. ; Forgie, I. ; Jablonka, B. ; Ruetten, H. ; Mari, A. ; McCarthy, M. I. ; Walker, M. ; McDonald, T. J. ; Perry, M. H. ; Pearson, E. R. ; Franks, P. W. ; 't Hart, L. M. ; Rutters, F. / Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time : An IMI-DIRECT study. In: Diabetic Medicine. 2021 ; Vol. 38, No. 2.

Bibtex

@article{e8c952d88f984162a139634e7a370b4b,
title = "Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time: An IMI-DIRECT study",
abstract = "Aim To examine the hypothesis that, based on their glucose curves during a seven-point oral glucose tolerance test, people at elevated type 2 diabetes risk can be divided into subgroups with different clinical profiles at baseline and different degrees of subsequent glycaemic deterioration.Methods We included 2126 participants at elevated type 2 diabetes risk from the Diabetes Research on Patient Stratification (IMI-DIRECT) study. Latent class trajectory analysis was used to identify subgroups from a seven-point oral glucose tolerance test at baseline and follow-up. Linear models quantified the associations between the subgroups with glycaemic traits at baseline and 18 months.Results At baseline, we identified four glucose curve subgroups, labelled in order of increasing peak levels as 1-4. Participants in Subgroups 2-4, were more likely to have higher insulin resistance (homeostatic model assessment) and a lower Matsuda index, than those in Subgroup 1. Overall, participants in Subgroups 3 and 4, had higher glycaemic trait values, with the exception of the Matsuda and insulinogenic indices. At 18 months, change in homeostatic model assessment of insulin resistance was higher in Subgroup 4 (beta = 0.36, 95% CI 0.13-0.58), Subgroup 3 (beta = 0.30; 95% CI 0.10-0.50) and Subgroup 2 (beta = 0.18; 95% CI 0.04-0.32), compared to Subgroup 1. The same was observed for C-peptide and insulin. Five subgroups were identified at follow-up, and the majority of participants remained in the same subgroup or progressed to higher peak subgroups after 18 months.Conclusions Using data from a frequently sampled oral glucose tolerance test, glucose curve patterns associated with different clinical characteristics and different rates of subsequent glycaemic deterioration can be identified.",
keywords = "IMPAIRED FASTING GLYCEMIA, BETA-CELL FUNCTION, TOLERANCE TEST, INSULIN SENSITIVITY, RISK, DYSGLYCEMIA, DEFINITION, RESISTANCE, PREDICTOR, SECRETION",
author = "M. Obura and Beulens, {J. W. J.} and R. Slieker and Koopman, {A. D. M.} and T. Hoekstra and G. Nijpels and P. Elders and Dekker, {J. M.} and Koivula, {R. W.} and A. Kurbasic and M. Laakso and Hansen, {T. H.} and M. Ridderstr{\aa}le and T. Hansen and I. Pavo and I. Forgie and B. Jablonka and H. Ruetten and A. Mari and McCarthy, {M. I.} and M. Walker and McDonald, {T. J.} and Perry, {M. H.} and Pearson, {E. R.} and Franks, {P. W.} and {'t Hart}, {L. M.} and F. Rutters",
year = "2021",
doi = "10.1111/dme.14428",
language = "English",
volume = "38",
journal = "Diabetic Medicine Online",
issn = "1464-5491",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time

T2 - An IMI-DIRECT study

AU - Obura, M.

AU - Beulens, J. W. J.

AU - Slieker, R.

AU - Koopman, A. D. M.

AU - Hoekstra, T.

AU - Nijpels, G.

AU - Elders, P.

AU - Dekker, J. M.

AU - Koivula, R. W.

AU - Kurbasic, A.

AU - Laakso, M.

AU - Hansen, T. H.

AU - Ridderstråle, M.

AU - Hansen, T.

AU - Pavo, I.

AU - Forgie, I.

AU - Jablonka, B.

AU - Ruetten, H.

AU - Mari, A.

AU - McCarthy, M. I.

AU - Walker, M.

AU - McDonald, T. J.

AU - Perry, M. H.

AU - Pearson, E. R.

AU - Franks, P. W.

AU - 't Hart, L. M.

AU - Rutters, F.

PY - 2021

Y1 - 2021

N2 - Aim To examine the hypothesis that, based on their glucose curves during a seven-point oral glucose tolerance test, people at elevated type 2 diabetes risk can be divided into subgroups with different clinical profiles at baseline and different degrees of subsequent glycaemic deterioration.Methods We included 2126 participants at elevated type 2 diabetes risk from the Diabetes Research on Patient Stratification (IMI-DIRECT) study. Latent class trajectory analysis was used to identify subgroups from a seven-point oral glucose tolerance test at baseline and follow-up. Linear models quantified the associations between the subgroups with glycaemic traits at baseline and 18 months.Results At baseline, we identified four glucose curve subgroups, labelled in order of increasing peak levels as 1-4. Participants in Subgroups 2-4, were more likely to have higher insulin resistance (homeostatic model assessment) and a lower Matsuda index, than those in Subgroup 1. Overall, participants in Subgroups 3 and 4, had higher glycaemic trait values, with the exception of the Matsuda and insulinogenic indices. At 18 months, change in homeostatic model assessment of insulin resistance was higher in Subgroup 4 (beta = 0.36, 95% CI 0.13-0.58), Subgroup 3 (beta = 0.30; 95% CI 0.10-0.50) and Subgroup 2 (beta = 0.18; 95% CI 0.04-0.32), compared to Subgroup 1. The same was observed for C-peptide and insulin. Five subgroups were identified at follow-up, and the majority of participants remained in the same subgroup or progressed to higher peak subgroups after 18 months.Conclusions Using data from a frequently sampled oral glucose tolerance test, glucose curve patterns associated with different clinical characteristics and different rates of subsequent glycaemic deterioration can be identified.

AB - Aim To examine the hypothesis that, based on their glucose curves during a seven-point oral glucose tolerance test, people at elevated type 2 diabetes risk can be divided into subgroups with different clinical profiles at baseline and different degrees of subsequent glycaemic deterioration.Methods We included 2126 participants at elevated type 2 diabetes risk from the Diabetes Research on Patient Stratification (IMI-DIRECT) study. Latent class trajectory analysis was used to identify subgroups from a seven-point oral glucose tolerance test at baseline and follow-up. Linear models quantified the associations between the subgroups with glycaemic traits at baseline and 18 months.Results At baseline, we identified four glucose curve subgroups, labelled in order of increasing peak levels as 1-4. Participants in Subgroups 2-4, were more likely to have higher insulin resistance (homeostatic model assessment) and a lower Matsuda index, than those in Subgroup 1. Overall, participants in Subgroups 3 and 4, had higher glycaemic trait values, with the exception of the Matsuda and insulinogenic indices. At 18 months, change in homeostatic model assessment of insulin resistance was higher in Subgroup 4 (beta = 0.36, 95% CI 0.13-0.58), Subgroup 3 (beta = 0.30; 95% CI 0.10-0.50) and Subgroup 2 (beta = 0.18; 95% CI 0.04-0.32), compared to Subgroup 1. The same was observed for C-peptide and insulin. Five subgroups were identified at follow-up, and the majority of participants remained in the same subgroup or progressed to higher peak subgroups after 18 months.Conclusions Using data from a frequently sampled oral glucose tolerance test, glucose curve patterns associated with different clinical characteristics and different rates of subsequent glycaemic deterioration can be identified.

KW - IMPAIRED FASTING GLYCEMIA

KW - BETA-CELL FUNCTION

KW - TOLERANCE TEST

KW - INSULIN SENSITIVITY

KW - RISK

KW - DYSGLYCEMIA

KW - DEFINITION

KW - RESISTANCE

KW - PREDICTOR

KW - SECRETION

U2 - 10.1111/dme.14428

DO - 10.1111/dme.14428

M3 - Journal article

C2 - 33067862

VL - 38

JO - Diabetic Medicine Online

JF - Diabetic Medicine Online

SN - 1464-5491

IS - 2

M1 - 14428

ER -

ID: 251945523